Skip to content
Homeโ€บ Europeโ€บ EEA Joint Committeeโ€บ Gazetteโ€บ Decision of the EEA Joint Committee...

Decision of the EEA Joint Committee No 39/2021 of 5 February 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/3]

Date: 11th January 2024
Jurisdiction: European Union
European Union

Read or download the official PDF of this gazette notification issued by the EEA Joint Committee on 11th January 2024.

Official Gazette Notification Text

Official Transcript

Official Journal EN of the European Union L series 2024/3 11.1.2024 DECISION OF THE EEA JOINT COMMITTEE No 39/2021 of 5 February 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/3] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (โ€œthe EEA Agreementโ€), and in particular Article...

PolicyIndex Takeaway
Get AI summary โ†’
  • โœ“ The Decision of the EEA Joint Committee No 39/2021 amends Annex II to the EEA Agreement to incorporate Commission Implementing Decision (EU) 2019/1396 regarding rules for the designation of expert panels in the field of medical devices.
  • โœ“ Annex II of the EEA Agreement is amended by inserting point 11a after point 11 in Chapter XXX.
  • โœ“ Point 11a references Commission Implementing Decision (EU) 2019/1396 of 10 September 2019, which lays down the rules for the application of Regulation (EU) 2017/745 concerning the designation of expert panels for medical devices.
  • โœ“ The decision entered into force on 6 February 2021, provided all notifications under Article 103(1) of the EEA Agreement were made.
  • โœ“ The authentic text of Implementing Decision (EU) 2019/1396 in Icelandic and Norwegian languages will be published in the EEA Supplement to the Official Journal of the European Union.

You might also want to explore

Get daily policy updates in your inbox

Choose the sectors and regulators you care about. We'll send only what matters to you.

No spam. Unsubscribe anytime.